General Information

What is ROS1 positive cancer?

ROS1 cancer, also known as ROS1 positive cancer, is a type of cancer that occurs when the ROS1 gene fuses with another gene, causing uncontrolled cell growth. ROS1 gene is inactive as an adult, but active in the womb. The regeneration of cells is occurring all the time inside our bodies. For reasons we don’t understand, the genetic abnormality which appears as a ROS1 fusion, means that the ROS1 gene is turned on to grow, divide and replicate. As a foetus its under control and will stop. But in ROS1 fusions, they keep on replicating and these develop as tumours.

There are ROS1 duplications and amplifications but the only one that matters in this case is the ROS1+ fusion which causes ROS1 positive cancer.

To determine if you have ROS1 positive cancer, analysis of the cancer cells needs to be performed. This can be done through obtaining tumour tissue samples, also called the Next Generation Sequencing (NGS) and/or performing blood tests (‘liquid biopsies’). Talk to your doctor to make sure one of these tests was performed. Your doctor may perform several of these tests at the same time to help confirm results.

Everyone! As of now, there is no known cause for developing ROS1 positive cancer. Generally seen in adenocarcinoma non-small cell lung cancer, the ROS1 gene is found in around 1-2% of non-small cell lung cancer (NSCLC) patients.

It’s vital to not look back, and instead the focus should be on living well and getting the cancer under control. Biologically it’s not associated with tobacco usage. ROS1-positive patients are often non-smokers and are younger than the typical lung cancer patient. When found in previous smokers, its likely occurred before their smoking cancer has developed, due to the early age that ROS1 is usually found at.

One cell to a perceivable lump on a CT takes about a year. Please note that the founder event of first cell with the genetic abnormality, which is then only typically discovered after cancer metastasises and is picked up in the healthcare system, is probably 5-10 years prior.

While its unknown what the actual causes are, there are some breadcrumbs like:

  • They are seen in polluted environments.
  • Exposure to diesel and charcoal particles plus wood burner fumes is also a tentative link.
  • Stress

These are all scientific hypotheses though, rather than causative factors – and as forementioned it’s not a productive use of time to try and play the blame game.

  • Majority of ROS1-positive cancer happens in lung cancer, although it can occur in other parts of the body such as brain, thyroid, pancreas, etc.
  • ROS1-positive carcinoma is a malignancy with an unidentified cause
  • Nearly 25% of ROS1 positive cancer patients will experience brain metastasis if they did not start with brain cancer as the primary cancer.
  • It is marginally more prevalent in females, comprising 64.5 percent of the ROS1 positive population.
  • ROS1 rearrangements are present in roughly 1-2% of patients, categorising it as one of the rarest cancer types.
  • ROS1-positive cancer develops from somatic mutations. Somatic mutations are alterations in DNA that transpire in somatic cells post-conception, excluding germ cells (sperm and egg). They are a typical aspect of aging and may result from deficiencies in DNA repair mechanisms or environmental stresses. Somatic mutations are not transmitted to offspring and are non-hereditary.
  • Individuals with ROS1-positive cancer typically exhibit a younger demographic than the general cancer population.

Reference

The most common of ROS1 positive Cancer is non-small cell lung cancer (NSCLC). The others primary cancers associated with ROS1 are listed below:

  • Glioblastoma (Brain Cancer)
  • Cholangiocarcinoma (Bile Duct Cancer)
  • Ovarian cancer
  • Thyroid cancer
  • Gastric adenocarcinoma
  • Colorectal cancer
  • Inflammatory myofibroblastictumour
  • Angiosarcoma
  • Epithelioid haemangioendothelioma
  • Small Cell Lung cancer